Fernando Sempértegui1, Bertha Estrella, Oswaldo Rodríguez, Dinor Gómez, Myryam Cabezas, Gilda Salgado, Lora L Sabin, Davidson H Hamer. 1. Corporación Ecuatoriana de Biotecnología, Quito, Ecuador (FS, BE, and OR); the Universidad Central del Ecuador, Escuela de Medicina, Quito, Ecuador (FS and BE); the Hospital de Niños Baca Ortiz, Quito, Ecuador (DG, MC, and GS); the Center for Global Health and Development, Boston University, Boston, MA (LLS and DHH); the Department of International Health, School of Public Health, Boston University, Boston, MA (LLS and DHH); the Section of Infectious Diseases, Department of Medicine, Boston University School of Medicine, Boston, MA (DHH); and the Gerald J and Dorothy R Friedman School of Nutrition Science and Policy, Tufts University, Medford, MA (DHH).
Abstract
BACKGROUND: Studies of zinc as an adjunct to treatment of severe pneumonia in children have shown mixed results, possibly because of poor information on zinc status and respiratory pathogens. OBJECTIVE: We evaluated the effect of zinc given with standard antimicrobial treatment on the duration of respiratory signs in children with severe pneumonia. Zinc status and pathogens were assessed. DESIGN:Children aged 2-59 mo with severe pneumonia who were admitted to the main children's hospital in Quito, Ecuador, were givenstandard antibiotics and randomly allocated to receive zinc supplements twice daily or a placebo. Measurements included anthropometric variables, breastfeeding, hemoglobin, plasma zinc, and common bacteria/viral respiratory pathogens. The primary outcome was time to resolution of respiratory signs. The secondary outcome was treatment failure. RESULTS: We enrolled 225 children in each group. There was no difference between groups in time to resolution of respiratory signs or treatment failure; pathogens were not associated with outcomes. Tachypnea and hypoxemia resolved faster in older children (P = 0.0001) than in younger ones. Higher basal zinc concentration (P = 0.011) and better height-for-age z score (HAZ) (P = 0.044) were associated with faster resolution of chest indrawing. Better weight-for-height z score (WHZ) (P = 0.031) and HAZ (P = 0.048) were associated with faster resolution of tachypnea. Increased C-reactive protein was associated with a longer duration of tachypnea (P = 0.044). CONCLUSIONS:Zinc did not affect time to pneumonia resolution or treatment failure, nor did type of respiratory pathogens affect outcomes. Higher basal zinc and better HAZ and WHZ were associated with reduced time to resolution of respiratory signs. These results suggest the need for prevention of chronic zinc deficiency and improvement of general nutritional status among Ecuadorian children.
RCT Entities:
BACKGROUND: Studies of zinc as an adjunct to treatment of severe pneumonia in children have shown mixed results, possibly because of poor information on zinc status and respiratory pathogens. OBJECTIVE: We evaluated the effect of zinc given with standard antimicrobial treatment on the duration of respiratory signs in children with severe pneumonia. Zinc status and pathogens were assessed. DESIGN:Children aged 2-59 mo with severe pneumonia who were admitted to the main children's hospital in Quito, Ecuador, were given standard antibiotics and randomly allocated to receive zinc supplements twice daily or a placebo. Measurements included anthropometric variables, breastfeeding, hemoglobin, plasma zinc, and common bacteria/viral respiratory pathogens. The primary outcome was time to resolution of respiratory signs. The secondary outcome was treatment failure. RESULTS: We enrolled 225 children in each group. There was no difference between groups in time to resolution of respiratory signs or treatment failure; pathogens were not associated with outcomes. Tachypnea and hypoxemia resolved faster in older children (P = 0.0001) than in younger ones. Higher basal zinc concentration (P = 0.011) and better height-for-age z score (HAZ) (P = 0.044) were associated with faster resolution of chest indrawing. Better weight-for-height z score (WHZ) (P = 0.031) and HAZ (P = 0.048) were associated with faster resolution of tachypnea. Increased C-reactive protein was associated with a longer duration of tachypnea (P = 0.044). CONCLUSIONS: Zinc did not affect time to pneumonia resolution or treatment failure, nor did type of respiratory pathogens affect outcomes. Higher basal zinc and better HAZ and WHZ were associated with reduced time to resolution of respiratory signs. These results suggest the need for prevention of chronic zinc deficiency and improvement of general nutritional status among Ecuadorian children.
Authors: Jorge Alberto Acevedo-Murillo; Miguel Leonardo García León; Verónica Firo-Reyes; Jorge Luis Santiago-Cordova; Alejandra Pamela Gonzalez-Rodriguez; Rosa María Wong-Chew Journal: Front Pediatr Date: 2019-11-14 Impact factor: 3.418
Authors: Peter P Moschovis; Emmanuel O D Addo-Yobo; Salem Banajeh; Noel Chisaka; David C Christiani; Douglas Hayden; Prakash Jeena; William B MacLeod; Greta Mino; Archana Patel; Shamim Qazi; Mathuram Santosham; Donald M Thea; Patricia L Hibberd Journal: Trop Med Int Health Date: 2015-07-15 Impact factor: 2.622
Authors: Stephen Howie; Christian Bottomley; Osaretin Chimah; Readon Ideh; Bernard Ebruke; Uduak Okomo; Charles Onyeama; Simon Donkor; Onike Rodrigues; Mary Tapgun; Marie Janneh; Claire Oluwalana; Bankole Kuti; Godwin Enwere; Pamela Esangbedo; Conor Doherty; Grant Mackenzie; Brian Greenwood; Tumani Corrah; Andrew Prentice; Richard Adegbola; Syed Zaman Journal: J Glob Health Date: 2018-06 Impact factor: 4.413